July 30, 2026 · JAMA · DOI: 10.1001/jama.2026.9268

Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial

Listen to this summary

This randomized clinical trial aimed to determine whether initiating dapagliflozin one day prior to elective cardiac surgery could reduce the incidence of acute kidney injury (AKI) within the first week post-surgery. The results showed that dapagliflozin significantly decreased AKI rates compared to placebo (28% vs. 52%), suggesting its potential as a preventive treatment in this patient population. Adverse events such as atrial fibrillation and reoperation rates were similar between the two groups.

Maartina J P Oosterom-Eijmael, Abraham H Hulst, Nelson P Monteiro de Oliveira, Ed D Niesten, Nicobert E Wietsma, Bastiaan M Gerritse, Thierry V Scohy, Thijs C D Rettig, Ferdinand T F Snellen, Magiel F Voogd, Marc B Godfried, Rients N de Boer, Jeroen Wink, Lisa M M van der Werff, Christa M Cobbaert, L Renee Ruhaak, Susanne Eberl, Benedikt Preckel, Markus W Hollmann, Jimmy Schenk, Jeroen Hermanides, Daniel H van Raalte, MERCURI-2 Study Group

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play